This site is intended for health professionals only

Dispensing doctors do try to keep prices down

pharmacy advice pharmacist  ppl


Dr Goldacre’s study is an interesting read and the Dispensing Doctors’ Association (DDA), of which I am Chairman, neither encourages, nor condones, the prescribing of costlier medicines.  Indeed, the GP contract has provisions which permit the NHS to take action against those who do so.

The study uses one month’s data from January 2015. Due to the continually changing reimbursement prices for medicines it is impossible, and disingenuous, to forecast one month’s estimated savings into a full year. There are also a number of one-off occurrences that can occur. For instance, in January 2015 there was a shortage of the valsartan generic.

Unlike community pharmacies, dispensing practices cannot use NCSO (no cheaper stock obtainable), and hence will always write a prescription for the brand if a generic medicine is in shortage. This puts a rather different complexion on the month snapshot that was taken in the study. In November 2018 alone, the price concessions for medicines for which there are shortages cost the NHS £23.3 million.

The cost of the medicines in the chosen four therapeutic areas of the study have decreased significantly, in addition to the prescribing of the brand originators, hence the paper really should have chosen more up-to-date data, which would show significantly decreased costs. Dispensing practices, like all practices, look to make efficiencies through increasing generic prescribing. For example, Olmetec prescriptions in 2015 cost £8.6 million, but in 2017 it was £0.78 million. That would have been rather less of a headline for your readers. 

The DDA has been concerned for some time that the system of reimbursement for drugs is not fit for purpose. For the last seven years, we have tried to interest the Department of Health and NHS England to develop a better one. To date, nothing has happened. 

We encourage our members to regularly audit their prescribing so that they ensure that they are acting in the best interests of the patient and the NHS. 

Dr Richard West is chairman at Dispensing Doctors’ Association and a GP in Stowmarket